Mario Raviglione
Director/Miembro de la Junta en Global Alliance for TB Drug Development .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Melvin Spigelman | M | 75 |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 21 años |
| David Norton | M | 72 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 11 años |
| Shalini Sharp | F | 49 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 9 años |
| Paul Sekhri | M | 66 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Sangita Reddy | M | 61 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 3 años |
| Sundar Kodiyalam | M | 62 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 3 años |
| Kim Schwartz | F | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 2 años |
| Jane Griffiths | M | 69 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 4 años |
| Willo Brock | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 10 años |
| Nancy Miller-Rich | F | 65 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 6 años |
| Ambassador Eric Goosby | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 3 años |
| Ariel Pablos-Méndez | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Mitchell Warren | M | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Rasha Hibri | F | - |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Caterina Bima | F | 64 |
University of Turin
| 7 años |
| Bruce Carter | M | 80 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | - |
| Riccardo Montanaro | M | 66 |
University of Turin
| 3 años |
| Paolo Gibello Ribatto | M | - |
University of Turin
| 4 años |
| Paola Marini | M | 66 |
University of Turin
| 4 años |
| Andrea Maggia | M | - |
University of Turin
| 6 años |
| Lucia Morselli | M | 67 |
University of Turin
| 2 años |
| Maria Grazia Roncarolo | M | 69 |
University of Turin
| 3 años |
| Claudio Serracane | M | 67 |
University of Turin
| 4 años |
| Andrea Beltratti | M | 65 |
University of Turin
| 4 años |
| Fabio Pasquini | M | 70 |
University of Turin
| 4 años |
| Riccardo Ranalli | M | 68 |
University of Turin
| 4 años |
| Georgios Vlamakis | M | 75 |
University of Turin
| 4 años |
| Gianpiero Giacardi | M | 66 |
University of Turin
| 3 años |
| Paolo Cafasso | M | 67 |
University of Turin
| 4 años |
| Roberto Orecchia | M | 71 |
University of Turin
| 4 años |
| G. Botta | M | 70 |
University of Turin
| 4 años |
| Claudio Recchi | M | 69 |
University of Turin
| 4 años |
| Daniela Ovazza | F | 67 |
University of Turin
| 4 años |
| Enrico Mario Amo | M | 67 |
University of Turin
| 4 años |
| Alessandra Trombetta | F | 65 |
University of Turin
| 4 años |
| Galeazzo Scarampi del Cairo | M | 68 |
University of Turin
| 3 años |
| Ezio Giovanni Basso | M | 69 |
University of Turin
| 4 años |
| Vittorio Rabajoli | M | - |
University of Turin
| 4 años |
| Camillo Venesio | M | 70 |
University of Turin
| 4 años |
| Oscar Pepino | M | 71 |
University of Turin
| 4 años |
| Stefano Marsaglia | M | 69 |
University of Turin
| 4 años |
| Carlo Pavesio | M | 68 |
University of Turin
| 3 años |
| Andrea Dogliotti | M | 74 |
University of Turin
| 4 años |
| Umberto Bocchino | M | 64 |
University of Turin
| 4 años |
| Riccardo Lodigiani | M | 66 |
University of Turin
| 4 años |
| Gilbert Marks | M | 66 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | 12 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Italia | 30 | 65.22% |
| Estados Unidos | 16 | 34.78% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Mario Raviglione
- Red Personal
